1. Anti-infection
  2. HCV
  3. HCV-IN-38

HCV-IN-38 是一种有效、具有选择性与口服活性的丙型肝炎病毒 (HCV) 抑制剂 (EC50=15 nM, SI=431)。HCV-IN-38 有较高的抗 HCV 活性和较低的细胞毒性。HCV-IN-38 具有良好的安全性和口服药代动力学。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

HCV-IN-38 Chemical Structure

HCV-IN-38 Chemical Structure

CAS No. : 3035807-39-4

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

HCV-IN-38 is a potent, selective and orally active HCV inhibitor (EC50=15 nM, SI=431). HCV-IN-38 has high anti-HCV activity and low cytotoxicity. HCV-IN-38 has a good safety and oral pharmacokinetic profile[1].

IC50 & Target

EC50: 15 nM (HCV) in Huh7.5 cells[1]

体外研究
(In Vitro)

HCV-IN-38 (compound 80) (0-20 μM; 72 hours) exhibits high anti-HCV activity with EC50=15 nM and low cytotoxicity with CC50=6.47 μM in Huh7.5 cells[1].
HCV-IN-38 (2 μM; 2 hours) has moderate permeability (0.5 < Papp < 2.5 (×10-6 cm/s))[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cytotoxicity Assay

Cell Line: Huh7.5 cells[1]
Concentration: 0-20 μM
Incubation Time: 72 hours
Result: Exhibited low cytotoxicity with CC50=6.47 μM.
体内研究
(In Vivo)

HCV-IN-38 (2 μM; 4 hours) has decent plasma stability (t1/2, rat=16.9 h and t1/2, human=19.9 h)[1].
HCV-IN-38 (2 mg/kg for i.p., 10 mg/kg for p.o., single) exhibits satisfying PK properties with an oral total exposure (AUC) of 1502 ng h/mL, medium in vivo clearance (38.3 mL/min/kg), Cmax of 452 ng/mL, and moderate bioavailability of 34%[1].
HCV-IN-38 (50-200 mg/kg; i.p., single) has modest safety profiles with LD50 values higher than 150 mg/kg[1].
Pharmacokinetic Parameters of HCV-IN-38 in Sprague-Dawley rats[1].

IV (2 mg/kg) PO (10 mg/kg)
AUC0-last (ng·h/mL) 889 ± 179 1502 ± 342
AUC0-inf (ng·h/mL) 898 ± 184 1525 ± 360
MRT0-last (h) 1.36 ± 0.182 2.95 ± 0.276
MRT0-inf (h) 1.45 ± 0.211 3.10 ± 0.290
Cmax (ng/mL) 452 ± 149
T1/2 (h) 1.24 ± 0.101 1.90 ± 0.492
Tlast (h) 8.00 12.0
Tmax (h) 1.00
Vdss (L/kg) 3.26 ± 0.426
Cl (mL/min/kg) 38.3 ± 8.89
F (%) 34

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: SD rats (180-220 g, n=3)[1]
Dosage: 2 or 10 mg/kg
Administration: i.v. and p.o., single (Pharmacokinetic Analysis)
Result: Exhibited satisfying PK properties with an oral total exposure (AUC) of 1502 ng h/mL, medium in vivo clearance (38.3 mL/min/kg), Cmax of 452 ng/mL, and moderate bioavailability of 34%.
Animal Model: Kunming mice (n=6)[1]
Dosage: 50, 100, 150, and 200 mg/kg
Administration: i.p., single
Result: Demonstrated modest safety profiles with LD50 values higher than 150 mg/kg.
分子量

500.90

Formula

C22H24ClF3N4O4

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献

HCV-IN-38 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
HCV-IN-38
目录号:
HY-115989
需求量: